Global Peripheral Parenteral Nutrition (PPN) Market Growth (Status and Outlook) 2024-2030

August 2024 | 105 pages | ID: GD0E0CF194A5EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Peripheral Parenteral Nutrition (PPN) market size was valued at US$ million in 2023. With growing demand in downstream market, the Peripheral Parenteral Nutrition (PPN) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.

The research report highlights the growth potential of the global Peripheral Parenteral Nutrition (PPN) market. Peripheral Parenteral Nutrition (PPN) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Peripheral Parenteral Nutrition (PPN). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Peripheral Parenteral Nutrition (PPN) market.

Key Features:

The report on Peripheral Parenteral Nutrition (PPN) market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Peripheral Parenteral Nutrition (PPN) market. It may include historical data, market segmentation by Type (e.g., Carbohydrates, Parenteral Lipid Emulsion), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Peripheral Parenteral Nutrition (PPN) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Peripheral Parenteral Nutrition (PPN) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Peripheral Parenteral Nutrition (PPN) industry. This include advancements in Peripheral Parenteral Nutrition (PPN) technology, Peripheral Parenteral Nutrition (PPN) new entrants, Peripheral Parenteral Nutrition (PPN) new investment, and other innovations that are shaping the future of Peripheral Parenteral Nutrition (PPN).

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Peripheral Parenteral Nutrition (PPN) market. It includes factors influencing customer ' purchasing decisions, preferences for Peripheral Parenteral Nutrition (PPN) product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Peripheral Parenteral Nutrition (PPN) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Peripheral Parenteral Nutrition (PPN) market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Peripheral Parenteral Nutrition (PPN) market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Peripheral Parenteral Nutrition (PPN) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Peripheral Parenteral Nutrition (PPN) market.

Market Segmentation:

Peripheral Parenteral Nutrition (PPN) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
  • Carbohydrates
  • Parenteral Lipid Emulsion
  • Single Dose Amino Acid Solution
  • Trace Elements
  • Vitamins and Minerals
Segmentation by application
  • Hospital
  • Home
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Eurofarma
  • Corporacion De Laboratorios Farmaceuticos
  • Baxter International Inc.
  • Kelun Pharma
  • B. Braun
  • Fresenius
  • Teva Pharmaceutical Industries
  • Pfizer (Hospira)
  • Ostuka Pharmaceutical
  • Laboratorios Biogalenic
  • Laboratorios Finlay
  • Grifols International
  • Fresenius Kabi
  • Sichuan Kelun Pharmaceutical
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Peripheral Parenteral Nutrition (PPN) Market Size 2019-2030
  2.1.2 Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Peripheral Parenteral Nutrition (PPN) Segment by Type
  2.2.1 Carbohydrates
  2.2.2 Parenteral Lipid Emulsion
  2.2.3 Single Dose Amino Acid Solution
  2.2.4 Trace Elements
  2.2.5 Vitamins and Minerals
2.3 Peripheral Parenteral Nutrition (PPN) Market Size by Type
  2.3.1 Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type (2019-2024)
2.4 Peripheral Parenteral Nutrition (PPN) Segment by Application
  2.4.1 Hospital
  2.4.2 Home
2.5 Peripheral Parenteral Nutrition (PPN) Market Size by Application
  2.5.1 Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application (2019-2024)

3 PERIPHERAL PARENTERAL NUTRITION (PPN) MARKET SIZE BY PLAYER

3.1 Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Players
  3.1.1 Global Peripheral Parenteral Nutrition (PPN) Revenue by Players (2019-2024)
  3.1.2 Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Players (2019-2024)
3.2 Global Peripheral Parenteral Nutrition (PPN) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PERIPHERAL PARENTERAL NUTRITION (PPN) BY REGIONS

4.1 Peripheral Parenteral Nutrition (PPN) Market Size by Regions (2019-2024)
4.2 Americas Peripheral Parenteral Nutrition (PPN) Market Size Growth (2019-2024)
4.3 APAC Peripheral Parenteral Nutrition (PPN) Market Size Growth (2019-2024)
4.4 Europe Peripheral Parenteral Nutrition (PPN) Market Size Growth (2019-2024)
4.5 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Peripheral Parenteral Nutrition (PPN) Market Size by Country (2019-2024)
5.2 Americas Peripheral Parenteral Nutrition (PPN) Market Size by Type (2019-2024)
5.3 Americas Peripheral Parenteral Nutrition (PPN) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Peripheral Parenteral Nutrition (PPN) Market Size by Region (2019-2024)
6.2 APAC Peripheral Parenteral Nutrition (PPN) Market Size by Type (2019-2024)
6.3 APAC Peripheral Parenteral Nutrition (PPN) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Peripheral Parenteral Nutrition (PPN) by Country (2019-2024)
7.2 Europe Peripheral Parenteral Nutrition (PPN) Market Size by Type (2019-2024)
7.3 Europe Peripheral Parenteral Nutrition (PPN) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Peripheral Parenteral Nutrition (PPN) by Region (2019-2024)
8.2 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Type (2019-2024)
8.3 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PERIPHERAL PARENTERAL NUTRITION (PPN) MARKET FORECAST

10.1 Global Peripheral Parenteral Nutrition (PPN) Forecast by Regions (2025-2030)
  10.1.1 Global Peripheral Parenteral Nutrition (PPN) Forecast by Regions (2025-2030)
  10.1.2 Americas Peripheral Parenteral Nutrition (PPN) Forecast
  10.1.3 APAC Peripheral Parenteral Nutrition (PPN) Forecast
  10.1.4 Europe Peripheral Parenteral Nutrition (PPN) Forecast
  10.1.5 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Forecast
10.2 Americas Peripheral Parenteral Nutrition (PPN) Forecast by Country (2025-2030)
  10.2.1 United States Peripheral Parenteral Nutrition (PPN) Market Forecast
  10.2.2 Canada Peripheral Parenteral Nutrition (PPN) Market Forecast
  10.2.3 Mexico Peripheral Parenteral Nutrition (PPN) Market Forecast
  10.2.4 Brazil Peripheral Parenteral Nutrition (PPN) Market Forecast
10.3 APAC Peripheral Parenteral Nutrition (PPN) Forecast by Region (2025-2030)
  10.3.1 China Peripheral Parenteral Nutrition (PPN) Market Forecast
  10.3.2 Japan Peripheral Parenteral Nutrition (PPN) Market Forecast
  10.3.3 Korea Peripheral Parenteral Nutrition (PPN) Market Forecast
  10.3.4 Southeast Asia Peripheral Parenteral Nutrition (PPN) Market Forecast
  10.3.5 India Peripheral Parenteral Nutrition (PPN) Market Forecast
  10.3.6 Australia Peripheral Parenteral Nutrition (PPN) Market Forecast
10.4 Europe Peripheral Parenteral Nutrition (PPN) Forecast by Country (2025-2030)
  10.4.1 Germany Peripheral Parenteral Nutrition (PPN) Market Forecast
  10.4.2 France Peripheral Parenteral Nutrition (PPN) Market Forecast
  10.4.3 UK Peripheral Parenteral Nutrition (PPN) Market Forecast
  10.4.4 Italy Peripheral Parenteral Nutrition (PPN) Market Forecast
  10.4.5 Russia Peripheral Parenteral Nutrition (PPN) Market Forecast
10.5 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Forecast by Region (2025-2030)
  10.5.1 Egypt Peripheral Parenteral Nutrition (PPN) Market Forecast
  10.5.2 South Africa Peripheral Parenteral Nutrition (PPN) Market Forecast
  10.5.3 Israel Peripheral Parenteral Nutrition (PPN) Market Forecast
  10.5.4 Turkey Peripheral Parenteral Nutrition (PPN) Market Forecast
  10.5.5 GCC Countries Peripheral Parenteral Nutrition (PPN) Market Forecast
10.6 Global Peripheral Parenteral Nutrition (PPN) Forecast by Type (2025-2030)
10.7 Global Peripheral Parenteral Nutrition (PPN) Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Eurofarma
  11.1.1 Eurofarma Company Information
  11.1.2 Eurofarma Peripheral Parenteral Nutrition (PPN) Product Offered
  11.1.3 Eurofarma Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Eurofarma Main Business Overview
  11.1.5 Eurofarma Latest Developments
11.2 Corporacion De Laboratorios Farmaceuticos
  11.2.1 Corporacion De Laboratorios Farmaceuticos Company Information
  11.2.2 Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Product Offered
  11.2.3 Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Corporacion De Laboratorios Farmaceuticos Main Business Overview
  11.2.5 Corporacion De Laboratorios Farmaceuticos Latest Developments
11.3 Baxter International Inc.
  11.3.1 Baxter International Inc. Company Information
  11.3.2 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Product Offered
  11.3.3 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Baxter International Inc. Main Business Overview
  11.3.5 Baxter International Inc. Latest Developments
11.4 Kelun Pharma
  11.4.1 Kelun Pharma Company Information
  11.4.2 Kelun Pharma Peripheral Parenteral Nutrition (PPN) Product Offered
  11.4.3 Kelun Pharma Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Kelun Pharma Main Business Overview
  11.4.5 Kelun Pharma Latest Developments
11.5 B. Braun
  11.5.1 B. Braun Company Information
  11.5.2 B. Braun Peripheral Parenteral Nutrition (PPN) Product Offered
  11.5.3 B. Braun Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 B. Braun Main Business Overview
  11.5.5 B. Braun Latest Developments
11.6 Fresenius
  11.6.1 Fresenius Company Information
  11.6.2 Fresenius Peripheral Parenteral Nutrition (PPN) Product Offered
  11.6.3 Fresenius Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Fresenius Main Business Overview
  11.6.5 Fresenius Latest Developments
11.7 Teva Pharmaceutical Industries
  11.7.1 Teva Pharmaceutical Industries Company Information
  11.7.2 Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Product Offered
  11.7.3 Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Teva Pharmaceutical Industries Main Business Overview
  11.7.5 Teva Pharmaceutical Industries Latest Developments
11.8 Pfizer (Hospira)
  11.8.1 Pfizer (Hospira) Company Information
  11.8.2 Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Product Offered
  11.8.3 Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Pfizer (Hospira) Main Business Overview
  11.8.5 Pfizer (Hospira) Latest Developments
11.9 Ostuka Pharmaceutical
  11.9.1 Ostuka Pharmaceutical Company Information
  11.9.2 Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Product Offered
  11.9.3 Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Ostuka Pharmaceutical Main Business Overview
  11.9.5 Ostuka Pharmaceutical Latest Developments
11.10 Laboratorios Biogalenic
  11.10.1 Laboratorios Biogalenic Company Information
  11.10.2 Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Product Offered
  11.10.3 Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 Laboratorios Biogalenic Main Business Overview
  11.10.5 Laboratorios Biogalenic Latest Developments
11.11 Laboratorios Finlay
  11.11.1 Laboratorios Finlay Company Information
  11.11.2 Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Product Offered
  11.11.3 Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
  11.11.4 Laboratorios Finlay Main Business Overview
  11.11.5 Laboratorios Finlay Latest Developments
11.12 Grifols International
  11.12.1 Grifols International Company Information
  11.12.2 Grifols International Peripheral Parenteral Nutrition (PPN) Product Offered
  11.12.3 Grifols International Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
  11.12.4 Grifols International Main Business Overview
  11.12.5 Grifols International Latest Developments
11.13 Fresenius Kabi
  11.13.1 Fresenius Kabi Company Information
  11.13.2 Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Product Offered
  11.13.3 Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
  11.13.4 Fresenius Kabi Main Business Overview
  11.13.5 Fresenius Kabi Latest Developments
11.14 Sichuan Kelun Pharmaceutical
  11.14.1 Sichuan Kelun Pharmaceutical Company Information
  11.14.2 Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Product Offered
  11.14.3 Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
  11.14.4 Sichuan Kelun Pharmaceutical Main Business Overview
  11.14.5 Sichuan Kelun Pharmaceutical Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Carbohydrates
Table 3. Major Players of Parenteral Lipid Emulsion
Table 4. Major Players of Single Dose Amino Acid Solution
Table 5. Major Players of Trace Elements
Table 6. Major Players of Vitamins and Minerals
Table 7. Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Peripheral Parenteral Nutrition (PPN) Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type (2019-2024)
Table 10. Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Peripheral Parenteral Nutrition (PPN) Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application (2019-2024)
Table 13. Global Peripheral Parenteral Nutrition (PPN) Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Player (2019-2024)
Table 15. Peripheral Parenteral Nutrition (PPN) Key Players Head office and Products Offered
Table 16. Peripheral Parenteral Nutrition (PPN) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Peripheral Parenteral Nutrition (PPN) Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Regions (2019-2024)
Table 21. Global Peripheral Parenteral Nutrition (PPN) Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Peripheral Parenteral Nutrition (PPN) Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Country (2019-2024)
Table 25. Americas Peripheral Parenteral Nutrition (PPN) Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type (2019-2024)
Table 27. Americas Peripheral Parenteral Nutrition (PPN) Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application (2019-2024)
Table 29. APAC Peripheral Parenteral Nutrition (PPN) Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Region (2019-2024)
Table 31. APAC Peripheral Parenteral Nutrition (PPN) Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type (2019-2024)
Table 33. APAC Peripheral Parenteral Nutrition (PPN) Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application (2019-2024)
Table 35. Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Country (2019-2024)
Table 37. Europe Peripheral Parenteral Nutrition (PPN) Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type (2019-2024)
Table 39. Europe Peripheral Parenteral Nutrition (PPN) Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Peripheral Parenteral Nutrition (PPN)
Table 48. Key Market Challenges & Risks of Peripheral Parenteral Nutrition (PPN)
Table 49. Key Industry Trends of Peripheral Parenteral Nutrition (PPN)
Table 50. Global Peripheral Parenteral Nutrition (PPN) Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Peripheral Parenteral Nutrition (PPN) Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Peripheral Parenteral Nutrition (PPN) Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Eurofarma Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 55. Eurofarma Peripheral Parenteral Nutrition (PPN) Product Offered
Table 56. Eurofarma Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Eurofarma Main Business
Table 58. Eurofarma Latest Developments
Table 59. Corporacion De Laboratorios Farmaceuticos Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 60. Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Product Offered
Table 61. Corporacion De Laboratorios Farmaceuticos Main Business
Table 62. Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Corporacion De Laboratorios Farmaceuticos Latest Developments
Table 64. Baxter International Inc. Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 65. Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Product Offered
Table 66. Baxter International Inc. Main Business
Table 67. Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Baxter International Inc. Latest Developments
Table 69. Kelun Pharma Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 70. Kelun Pharma Peripheral Parenteral Nutrition (PPN) Product Offered
Table 71. Kelun Pharma Main Business
Table 72. Kelun Pharma Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Kelun Pharma Latest Developments
Table 74. B. Braun Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 75. B. Braun Peripheral Parenteral Nutrition (PPN) Product Offered
Table 76. B. Braun Main Business
Table 77. B. Braun Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. B. Braun Latest Developments
Table 79. Fresenius Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 80. Fresenius Peripheral Parenteral Nutrition (PPN) Product Offered
Table 81. Fresenius Main Business
Table 82. Fresenius Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Fresenius Latest Developments
Table 84. Teva Pharmaceutical Industries Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 85. Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Product Offered
Table 86. Teva Pharmaceutical Industries Main Business
Table 87. Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Teva Pharmaceutical Industries Latest Developments
Table 89. Pfizer (Hospira) Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 90. Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Product Offered
Table 91. Pfizer (Hospira) Main Business
Table 92. Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Pfizer (Hospira) Latest Developments
Table 94. Ostuka Pharmaceutical Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 95. Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Product Offered
Table 96. Ostuka Pharmaceutical Main Business
Table 97. Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Ostuka Pharmaceutical Latest Developments
Table 99. Laboratorios Biogalenic Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 100. Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Product Offered
Table 101. Laboratorios Biogalenic Main Business
Table 102. Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Laboratorios Biogalenic Latest Developments
Table 104. Laboratorios Finlay Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 105. Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Product Offered
Table 106. Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. Laboratorios Finlay Main Business
Table 108. Laboratorios Finlay Latest Developments
Table 109. Grifols International Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 110. Grifols International Peripheral Parenteral Nutrition (PPN) Product Offered
Table 111. Grifols International Main Business
Table 112. Grifols International Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Grifols International Latest Developments
Table 114. Fresenius Kabi Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 115. Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Product Offered
Table 116. Fresenius Kabi Main Business
Table 117. Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Fresenius Kabi Latest Developments
Table 119. Sichuan Kelun Pharmaceutical Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 120. Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Product Offered
Table 121. Sichuan Kelun Pharmaceutical Main Business
Table 122. Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. Sichuan Kelun Pharmaceutical Latest Developments

LIST OF FIGURES

Figure 1. Peripheral Parenteral Nutrition (PPN) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Peripheral Parenteral Nutrition (PPN) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Peripheral Parenteral Nutrition (PPN) Sales Market Share by Country/Region (2023)
Figure 8. Peripheral Parenteral Nutrition (PPN) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type in 2023
Figure 10. Peripheral Parenteral Nutrition (PPN) in Hospital
Figure 11. Global Peripheral Parenteral Nutrition (PPN) Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Peripheral Parenteral Nutrition (PPN) in Home
Figure 13. Global Peripheral Parenteral Nutrition (PPN) Market: Home (2019-2024) & ($ Millions)
Figure 14. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application in 2023
Figure 15. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Player in 2023
Figure 16. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Peripheral Parenteral Nutrition (PPN) Market Size 2019-2024 ($ Millions)
Figure 18. APAC Peripheral Parenteral Nutrition (PPN) Market Size 2019-2024 ($ Millions)
Figure 19. Europe Peripheral Parenteral Nutrition (PPN) Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size 2019-2024 ($ Millions)
Figure 21. Americas Peripheral Parenteral Nutrition (PPN) Value Market Share by Country in 2023
Figure 22. United States Peripheral Parenteral Nutrition (PPN) Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Peripheral Parenteral Nutrition (PPN) Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Peripheral Parenteral Nutrition (PPN) Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Peripheral Parenteral Nutrition (PPN) Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Region in 2023
Figure 27. APAC Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type in 2023
Figure 28. APAC Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application in 2023
Figure 29. China Peripheral Parenteral Nutrition (PPN) Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Peripheral Parenteral Nutrition (PPN) Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Peripheral Parenteral Nutrition (PPN) Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Peripheral Parenteral Nutrition (PPN) Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Peripheral Parenteral Nutrition (PPN) Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Peripheral Parenteral Nutrition (PPN) Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Country in 2023
Figure 36. Europe Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type (2019-2024)
Figure 37. Europe Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application (2019-2024)
Figure 38. Germany Peripheral Parenteral Nutrition (PPN) Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Peripheral Parenteral Nutrition (PPN) Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Peripheral Parenteral Nutrition (PPN) Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Peripheral Parenteral Nutrition (PPN) Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Peripheral Parenteral Nutrition (PPN) Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Peripheral Parenteral Nutrition (PPN) Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Peripheral Parenteral Nutrition (PPN) Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Peripheral Parenteral Nutrition (PPN) Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Peripheral Parenteral Nutrition (PPN) Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Peripheral Parenteral Nutrition (PPN) Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Peripheral Parenteral Nutrition (PPN) Market Size 2025-2030 ($ Millions)
Figure 52. APAC Peripheral Parenteral Nutrition (PPN) Market Size 2025-2030 ($ Millions)
Figure 53. Europe Peripheral Parenteral Nutrition (PPN) Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size 2025-2030 ($ Millions)
Figure 55. United States Peripheral Parenteral Nutrition (PPN) Market Size 2025-2030 ($ Millions)
Figure 56. Canada Peripheral Parenteral Nutrition (PPN) Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Peripheral Parenteral Nutrition (PPN) Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Peripheral Parenteral Nutrition (PPN) Market Size 2025-2030 ($ Millions)
Figure 59. China Peripheral Parenteral Nutrition (PPN) Market Size 2025-2030 ($ Millions)
Figure 60. Japan Peripheral Parenteral Nutrition (PPN) Market Size 2025-2030 ($ Millions)
Figure 61. Korea Peripheral Parenteral Nutrition (PPN) Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Peripheral Parenteral Nutrition (PPN) Market Size 2025-2030 ($ Millions)
Figure 63. India Peripheral Parenteral Nutrition (PPN) Market Size 2025-2030 ($ Millions)
Figure 64. Australia Peripheral Parenteral Nutrition (PPN) Market Size 2025-2030 ($ Millions)
Figure 65. Germany Peripheral Parenteral Nutrition (PPN) Market Size 2025-2030 ($ Millions)
Figure 66. France Peripheral Parenteral Nutrition (PPN) Market Size 2025-2030 ($ Millions)
Figure 67. UK Peripheral Parenteral Nutrition (PPN) Market Size 2025-2030 ($ Millions)
Figure 68. Italy Peripheral Parenteral Nutrition (PPN) Market Size 2025-2030 ($ Millions)
Figure 69. Russia Peripheral Parenteral Nutrition (PPN) Market Size 2025-2030 ($ Millions)
Figure 70. Spain Peripheral Parenteral Nutrition (PPN) Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Peripheral Parenteral Nutrition (PPN) Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Peripheral Parenteral Nutrition (PPN) Market Size 2025-2030 ($ Millions)
Figure 73. Israel Peripheral Parenteral Nutrition (PPN) Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Peripheral Parenteral Nutrition (PPN) Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Peripheral Parenteral Nutrition (PPN) Market Size 2025-2030 ($ Millions)
Figure 76. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share Forecast by Application (2025-2030)


More Publications